Current and historical daily PE Ratio for Biofrontera AG (
XTER:B8FK
) from 2007 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biofrontera AG stock (XTER:B8FK) PE ratio as of Jun 10 2024 is 24.64.
More Details
Biofrontera AG (XTER:B8FK) PE Ratio (TTM) Chart
Biofrontera AG (XTER:B8FK) PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Total 1292
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Biofrontera AG PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 24.6 | 2024-04-08 | 62.8 |
| 2024-06-07 | 24.6 | 2024-04-05 | 66.7 |
| 2024-06-06 | 22.7 | 2024-04-04 | 64.7 |
| 2024-06-05 | 24.3 | 2024-04-03 | 63.6 |
| 2024-06-04 | 25.4 | 2024-04-02 | 61.6 |
| 2024-06-03 | 26.5 | 2024-04-01 | 65.9 |
| 2024-05-31 | 28.1 | 2024-03-29 | 65.9 |
| 2024-05-30 | 30.8 | 2024-03-28 | 65.9 |
| 2024-05-29 | 33.4 | 2024-03-27 | At Loss |
| 2024-05-28 | 33.4 | 2024-03-26 | At Loss |
| 2024-05-27 | 34.3 | 2024-03-25 | At Loss |
| 2024-05-24 | 34.2 | 2024-03-22 | At Loss |
| 2024-05-23 | 35.9 | 2024-03-21 | At Loss |
| 2024-05-22 | 35.0 | 2024-03-20 | At Loss |
| 2024-05-21 | 32.4 | 2024-03-19 | At Loss |
| 2024-05-20 | 31.8 | 2024-03-18 | At Loss |
| 2024-05-17 | 32.2 | 2024-03-15 | At Loss |
| 2024-05-16 | 32.7 | 2024-03-14 | At Loss |
| 2024-05-15 | 37.5 | 2024-03-13 | At Loss |
| 2024-05-14 | 39.7 | 2024-03-12 | At Loss |
| 2024-05-13 | 62.4 | 2024-03-11 | At Loss |
| 2024-05-10 | 65.9 | 2024-03-08 | At Loss |
| 2024-05-09 | 67.8 | 2024-03-07 | At Loss |
| 2024-05-08 | 67.4 | 2024-03-06 | At Loss |
| 2024-05-07 | 67.4 | 2024-03-05 | At Loss |
| 2024-05-06 | 67.4 | 2024-03-04 | At Loss |
| 2024-05-03 | 67.4 | 2024-03-01 | At Loss |
| 2024-05-02 | 67.4 | 2024-02-29 | At Loss |
| 2024-05-01 | 67.4 | 2024-02-28 | At Loss |
| 2024-04-30 | 67.4 | 2024-02-27 | At Loss |
| 2024-04-29 | 67.4 | 2024-02-26 | At Loss |
| 2024-04-26 | 64.3 | 2024-02-23 | At Loss |
| 2024-04-25 | 63.2 | 2024-02-22 | At Loss |
| 2024-04-24 | 64.3 | 2024-02-21 | At Loss |
| 2024-04-23 | 66.7 | 2024-02-20 | At Loss |
| 2024-04-22 | 66.7 | 2024-02-19 | At Loss |
| 2024-04-19 | 60.1 | 2024-02-16 | At Loss |
| 2024-04-18 | 62.8 | 2024-02-15 | At Loss |
| 2024-04-17 | 67.4 | 2024-02-14 | At Loss |
| 2024-04-16 | 65.5 | 2024-02-13 | At Loss |
| 2024-04-15 | 65.5 | 2024-02-12 | At Loss |
| 2024-04-12 | 65.5 | 2024-02-09 | At Loss |
| 2024-04-11 | 65.5 | 2024-02-08 | At Loss |
| 2024-04-10 | 65.5 | 2024-02-07 | At Loss |
| 2024-04-09 | 65.5 | 2024-02-06 | At Loss |
Biofrontera AG (XTER:B8FK) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biofrontera AG
ISIN : DE000A4BGGM7
Compare
Compare
Traded in other countries / regions
B8FK.Germany0DOL.UKBFFTF.USA IPO Date
2007-12-28Description
Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers